Semaglutide
A long-acting GLP-1 receptor agonist studied in glycemic control and weight-related research models.
Half-life
~7 days
Typical vial
5 mg / 10 mg
Mechanism
GLP-1 receptor activation is associated with insulin secretion, glucagon suppression, and delayed gastric emptying.
Research Applications
- Glycemic studies
- Appetite regulation
- Metabolic models
Handling & Storage
Store lyophilized at -20°C. Reconstitute with water and refrigerate.
Compliance notice: All materials are sold strictly for in vitro laboratory research. Not a drug, supplement, food, or cosmetic. Not for human or veterinary use, diagnosis, treatment, or consumption. No medical claims are made or implied. Buyers must be qualified researchers ≥21 years of age and agree to handle materials in compliance with all applicable local, state, and federal laws.